An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer

Xiang Ling(Roswell Park Comprehensive Cancer Center), Fengzhi Li(Roswell Park Comprehensive Cancer Center)
Journal of Experimental & Clinical Cancer Research
October 1, 2018
Cited by 67


Related Papers